RIGEL PHARMACEUTICALS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $17.2M | $101.3M | $40.1M |
| Jun 2017 | $15.9M | $85.5M | $32.6M |
| Sep 2017 | $15.1M | $71.3M | $25.9M |
| Dec 2017 | $18.5M | $119.1M | $38.3M |
| Mar 2018 | $19.0M | $98.8M | $40.1M |
| Jun 2018 | $17.7M | $141.2M | $65.1M |
| Sep 2018 | $19.7M | $123.2M | $61.5M |
| Dec 2018 | $29.2M | $139.1M | $76.3M |
| Mar 2019 | $77.5M | $172.8M | $74.7M |
| Jun 2019 | $77.9M | $156.2M | $44.2M |
| Sep 2019 | $87.2M | $156.1M | $39.1M |
| Dec 2019 | $93.8M | $147.6M | $22.5M |
| Mar 2020 | $64.9M | $143.4M | $45.2M |
| Jun 2020 | $74.8M | $138.0M | $36.5M |
| Sep 2020 | $72.1M | $123.1M | $36.6M |
| Dec 2020 | $76.4M | $110.4M | $30.4M |
| Mar 2021 | $137.7M | $216.0M | $20.0M |
| Jun 2021 | $133.5M | $201.6M | $84.8M |
| Sep 2021 | $136.8M | $186.5M | $30.4M |
| Dec 2021 | $137.0M | $167.3M | $18.9M |
| Mar 2022 | $142.3M | $149.1M | $24.7M |
| Jun 2022 | $131.7M | $128.0M | $27.2M |
| Sep 2022 | $135.4M | $115.6M | $29.9M |
| Dec 2022 | $147.9M | $134.3M | $24.5M |
| Mar 2023 | $147.9M | $123.6M | $40.3M |
| Jun 2023 | $145.2M | $117.1M | $48.8M |
| Sep 2023 | $147.2M | $115.3M | $45.4M |
| Dec 2023 | $145.9M | $117.2M | $32.8M |
| Mar 2024 | $158.2M | $126.5M | $25.6M |
| Jun 2024 | $158.3M | $128.4M | $36.1M |
| Sep 2024 | $154.1M | $139.4M | $51.7M |
| Dec 2024 | $160.7M | $164.0M | $56.7M |
| Mar 2025 | $157.4M | $176.0M | $45.7M |
| Jun 2025 | $124.8M | $206.7M | $53.4M |
| Sep 2025 | $124.9M | $242.5M | $48.5M |
| Dec 2025 | $122.1M | $513.6M | $40.6M |
| Mar 2026 | $104.7M | $504.6M | $24.4M |
| Jun 2026 | $95.6M | $521.1M | $60.8M |